| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| BLACKBERRY | 18 | 4 | -14,07 % | ||
| RIVIAN AUTOMOTIVE | 14 | 22 | +9,01 % | ||
| TRUMP MEDIA & TECHNOLOGY GROUP | 13 | 53 | +6,53 % | ||
| BIRKENSTOCK | 13 | 2 | +1,08 % | ||
| ALMONTY | 12 | 1 | -0,84 % | ||
| MISSION PRODUCE | 11 | - | +5,31 % | ||
| LUNDIN MINING | 10 | 2 | +0,35 % | ||
| DRAFTKINGS | 8 | 5 | +0,65 % | ||
| TALON METALS | 8 | 2 | +33,21 % | ||
| CUE BIOPHARMA | 8 | 2 | -18,65 % |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 20:54 | Curaleaf Holdings Inc: Curaleaf cancels acquisition of Cannabist assets | 1 | Stockwatch | ||
| 20:50 | ThyssenKrupp Nucera im Wasserstoff-Blues, FuelCell Energy entfacht neue KI-Fantasien, Bloom Energy setzt zur Erholung an und auch Oracle zeigt sich etwas fester | 98 | NTG24.de | Hier und dort gab es zwar eine kleine Erholung in den Herbstmonaten zu sehen, doch insgesamt haben Wasserstoff-Aktien viel von ihrem einstigen Glanz verloren. Der große Durchbruch der Technologie blieb... ► Artikel lesen | |
| 20:49 | Bombardier's Global 8000 jet receives certification from U.S. aviation regulator | 2 | BNN Bloomberg | ||
| 20:48 | Hansa Biopharma AB: Hansa Biopharma Submits BLA to FDA for Imlifidase in desensitization for Kidney Transplantation | 80 | PR Newswire | The application is based on the successful outcome of the pivotal US Phase 3 ConfIdeS trial in highly sensitized patientsImlifidase is an enzyme that rapidly and efficiently cleaves all types... ► Artikel lesen | |
| 20:46 | Trump verkündet Abkommen: Roche und Novartis senken US-Preise | 6 | 20min.ch | ||
| 20:46 | Novartis Pharma AG: Novartis and US government reach agreement on lowering drug prices in the US | 105 | GlobeNewswire (Europe) | Novartis agrees to take actions aimed at meeting US Administration priorities for drug pricingAdditional Novartis medicines will be made available through direct-to-patient platforms in 2026Company... ► Artikel lesen | |
| 20:46 | Gilead stimmt Preissenkungen für Medikamente in den USA im Rahmen einer Vereinbarung mit der Trump-Regierung zu | 2 | Investing.com Deutsch | ||
| 20:45 | Dow Jones' Merck, Other Drugmakers Strike Drug-Pricing Bargains With Trump | 2 | Investor's Business Daily | ||
| 20:42 | North Peak Resources Ltd: North Peak drills 2.34 g/t Au, 68 g/t Ag at Prospect | 1 | Stockwatch | ||
| 20:42 | UPM Leuna biorefinery begins commercial production of industrial sugars | 3 | Lesprom | ||
| 20:39 | HANSA BIOPHARMA AB: Hansa Biopharma Submits BLA to FDA for Imlifidase in desensitization for Kidney Transplantation | 3 | Cision News | ||
| 20:39 | Ohne Premium weniger Werbung: Diese YouTube-Tricks solltet ihr ausprobieren | 3 | GIGA | ||
| 20:37 | Vizsla Silver Acquires Fresnillo Claims Near Panuco | 3 | Mexico Business News | ||
| 20:37 | Trump's Venezuela Strategy And The National Security Playbook | 1 | Forbes | ||
| 20:34 | Namib Minerals Plans Redwing Gold Mine Restart in Zimbabwe, Aiming for Major Output Growth | 1 | Ecofin Agency | ||
| 20:34 | Sanofi: Sanofi reaches agreement with the US government to lower medicine costs while strengthening innovation | 152 | GlobeNewswire (Europe) | Sanofi reaches agreement with the US government to lower medicine costs while strengthening innovation
Agreement delivers on President Trump's four requests, establishing a framework for lower prices... ► Artikel lesen | |
| 20:31 | Evening digest: Bitcoin ETF inflows surge, BOJ hikes rates, FTC Clears Nvidia-Intel deal | 2 | iNVEZZ.com | ||
| 20:30 | ITM Power-Aktie sorgt für Aufsehen: Profis warnen vor kritischer Phase - BREAKING NEWS! | Hebelschein-Spekulant | |||
| 20:30 | Triple One Metals Inc: Triple One shareholders elect directors at AGM | 1 | Stockwatch | ||
| 20:30 | UnitedHealth Group outlines action plans for operational improvement following independent audits | 2 | FierceHealthcare |